Patents by Inventor Zhongqiu Xie

Zhongqiu Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957682
    Abstract: In one aspect, the disclosure relates to compounds useful to regulate, limit, or inhibit the expression of AVIL (advillin), methods of making same, pharmaceutical compositions comprising same, and methods of treating disorders associated with AVIL dysregulation using same. In aspects, the disclosed compounds, compositions and methods are useful for treating disorders or diseases in which the regulation, limitation, or inhibition of the expression of AVIL can be clinically useful, such as, for example, the treatment of cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Grant
    Filed: June 27, 2022
    Date of Patent: April 16, 2024
    Assignee: University of Virginia Patent Foundation
    Inventors: Hui Li, Zhongqiu Xie
  • Publication number: 20230364087
    Abstract: Disclosed herein are silencing oligonucleotides useful to regulate, limit, or inhibit the expression of AVIL (advillin). Also disclosed herein are methods for treating disorders associated with AVIL dysregulation using same. In some embodiments, the method involves treating a cancer, such as glioblastomas, rhabdosarcomas, gliomas, lung cancer, bladder cancer, or renal cancer.
    Type: Application
    Filed: April 25, 2023
    Publication date: November 16, 2023
    Inventors: Hui LI, Zhongqiu XIE
  • Publication number: 20230018590
    Abstract: In one aspect, the disclosure relates to compounds useful to regulate, limit, or inhibit the expression of AVIL (advillin), methods of making same, pharmaceutical compositions comprising same, and methods of treating disorders associated with AVIL dysregulation using same. In aspects, the disclosed compounds, compositions and methods are useful for treating disorders or diseases in which the regulation, limitation, or inhibition of the expression of AVIL can be clinically useful, such as, for example, the treatment of cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Application
    Filed: June 27, 2022
    Publication date: January 19, 2023
    Inventors: Hui Li, Zhongqiu Xie
  • Publication number: 20220213055
    Abstract: In one aspect, the disclosure relates to compounds useful to regulate, limit, or inhibit the expression of AVIL (advillin), methods of making same, pharmaceutical compositions comprising same, and methods of treating disorders associated with AVIL dysregulation using same. In aspects, the disclosed compounds, compositions and methods are useful for treating disorders or diseases in which the regulation, limitation, or inhibition of the expression of AVIL can be clinically useful, such as, for example, the treatment of cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Application
    Filed: May 2, 2020
    Publication date: July 7, 2022
    Inventors: Hui Li, Zhongqiu Xie, Pawel Lukasz Janczyk, Michael Kenneth Hilinski, Philip Lee Hahn, Johnathon Daniel Dooley
  • Patent number: 11369608
    Abstract: In one aspect, the disclosure relates to compounds useful to regulate, limit, or inhibit the expression of AVIL (advillin), methods of making same, pharmaceutical compositions comprising same, and methods of treating disorders associated with AVIL dys-regulation using same. In aspects, the disclosed compounds, compositions and methods are useful for treating disorders or diseases in which the regulation, limitation, or inhibition of the expression of AVIL can be clinically useful, such as, for example, the treatment of cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: June 28, 2022
    Assignee: University of Virginia Patent Foundation
    Inventors: Hui Li, Zhongqiu Xie
  • Publication number: 20200316063
    Abstract: In one aspect, the disclosure relates to compounds useful to regulate, limit, or inhibit the expression of AVIL (advillin), methods of making same, pharmaceutical compositions comprising same, and methods of treating disorders associated with AVIL dys-regulation using same. In aspects, the disclosed compounds, compositions and methods are useful for treating disorders or diseases in which the regulation, limitation, or inhibition of the expression of AVIL can be clinically useful, such as, for example, the treatment of cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Application
    Filed: October 26, 2018
    Publication date: October 8, 2020
    Inventors: Hui Li, Zhongqiu Xie